Exeltis is a leading player in the pharmaceutical sector, dedicated to rethinking healthcare with a commitment to innovation and excellence. It emerged as a result of the evolution and sustained growth of Insud Pharma, an integrated health sciences group. Combining expertise and experience with an innovative spirit, Exeltis has become a global organization with the capacity to discover, develop, produce, and market medicinal products and medical devices worldwide. With a firm focus on human wellbeing and health, they have expanded their operations to every continent, ensuring rapid and effective access to a wide range of products for patients globally. Founded in 2003, Exeltis prides itself on being an entrepreneurial organization in constant evolution, driven by an innovative spirit and a commitment to meeting patients' unmet needs. Their collaborative approach is evident in their alliances with leading pharmaceutical companies that share their enthusiasm, as they strive to progress together in advancing healthcare. The company's dedication to providing better therapeutic solutions and reaching more people worldwide reflects in their slogan, "Rethinking healthcare." Exeltis operates within the Health Care and Pharmaceutical industries, consistently prioritizing people as their core concern and guiding force. Although specific details about their headquarters or recent investments are not provided, the organization’s focus on global presence and dedication to improving the quality of life of millions of people worldwide is unmistakable.
There is no investment information
No recent news or press coverage available for Exeltis.